ITeos Therapeutics Inc (NAS:ITOS)
$ 8.34 -0.21 (-2.46%) Market Cap: 304.69 Mil Enterprise Value: -170.82 Mil PE Ratio: 0 PB Ratio: 0.48 GF Score: 46/100

Iteos Therapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript

Feb 14, 2023 / 03:00PM GMT
Release Date Price: $18.93 (-1.82%)
Daina Graybosch
SVB Securities - Analyst

Good morning, everyone. My name is Daina Graybosch. I'm the immuno-oncology analyst here at SVB Securities. And I'm excited to have the management team from iTeos Therapeutics for a fireside chat. I'm going to hand it over to Michel, who's going to walk through a few introductory slides, everybody, starting with the same context on the pipeline, and then we'll move into the Q&A. (Conference Instructions)

And with that, I'll turn it over to Michel.

Michel Detheux
iTeos Therapeutics, Inc. - President & CEO

Thank you, Daina, and thank you to SVB for the opportunity to present iTeos's story today. Good morning to everybody listening to the presentation today on the webcast. When I founded iTeos my mission, then and now, has been to build a company that would master human immunology to save the most relevant targets and [give a better sense]. And we are going to show you what we have learned since -- from the [biology].

During this presentation, we make forward-looking statements. Let's start

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot